2023
DOI: 10.1016/j.ahr.2023.100121
|View full text |Cite
|
Sign up to set email alerts
|

Classification of MCI patients using vergence eye movements and pupil responses obtained during a visual oddball test

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
1

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 18 publications
0
3
0
Order By: Relevance
“…In patients with MCI, attended stimuli are accompanied by a weak enhancement, whereas Alzheimer patients show no difference in vergence responses to attended and unattended stimuli. Such models can even predict the risk of patients with MCI developing Alzheimer's disease [19].…”
Section: Introductionmentioning
confidence: 99%
“…In patients with MCI, attended stimuli are accompanied by a weak enhancement, whereas Alzheimer patients show no difference in vergence responses to attended and unattended stimuli. Such models can even predict the risk of patients with MCI developing Alzheimer's disease [19].…”
Section: Introductionmentioning
confidence: 99%
“…Current imaging tools for diagnosing and classifying MCI and AD mainly include MRI and PET. MRI can identify brain structural and functional changes caused by AD at different stages (such as hippocampal volume, cortical thickness) (Hashemi et al 2023 ); 18F-FDG PET evaluates brain metabolism by measuring local glucose consumption in brain tissue (Qiu et al 2022 ). Recent research shows that, in the MCI phase, 18F-FDG PET may show features of neurodegeneration earlier than MRI (Kang et al 2021 ; Cahill and Huang 2017 ).…”
Section: Introductionmentioning
confidence: 99%
“…In MCI patients, attended stimuli are accompanied by a weak enhancement whereas Alzheimer patients show no difference in vergence responses to attended and unattended stimuli. Such models can even predict the risk of MCI patients developing Alzheimer's disease (Hashemi et al, 2023).…”
Section: Introductionmentioning
confidence: 99%